Relationship between updated systolic blood pressure (SBP), right, and updated HbA1c, left, and the incidence of microvascular complications (closed symbols)

Slides:

Advertisements

Similar presentations

BY Dr. Khaled Helmy Al Mahmora Chest Hospital BY Dr. Khaled Helmy Al Mahmora Chest Hospital Treatment Of Hypertension In Diabetes.

Advertisements

UKPDS Paper 36 Slides © University of Oxford Diabetes Trials Unit UKPDS slides are copyright and remain the property of the University of Oxford Diabetes.

UKPDS Paper 35 Slides © University of Oxford Diabetes Trials Unit

Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.

The concept of Diabetes & CV risk: A lifetime risk challenge

Diabetic Microvascular Disease: The Role of Glycemic Control and the Impact on Public Health Robert E. Ratner, MD MedStar Research Institute Georgetown.

Blood glucose: is lower better for diabetic patients?

Microvascular and Macrovascular Complications in Hispanic Americans.

1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.

FDA Endocrinologic and Metabolic Drugs Advisory Committee 1st June 2008 Rury Holman Clinical outcomes with anti-diabetic drugs: What we already know.

Comprehensive Diabetes Care. Comprehensive Diabetes Care: HbA1c Testing (Commercial) Source: National Committee for Quality Assurance, The State of Health.

UKHDS (UKPDS): UK Hypertension in Diabetes Study Purpose To determine whether tight control of blood pressure (aiming for BP

Part 3. Diabetes Report Card: HbA 1c Levels in the United States Hoerger TJ, et al. Diabetes Care. 2008;31: Patients (%) HbA 1c (%)

Date of download: 5/28/2016 From: United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved.

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Safety and Efficacy of Low Blood Pressures Among.

From: Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study Ann Intern Med. 2015;163(5):

Dr John Cox Diabetes in Primary Care Conference Cork

Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study Dr Jack R W Brownrigg,

Volume 20, Issue 7, Pages (July 2017)

Volume 352, Issue 9131, Pages (September 1998)

Copyright © 2014 American Medical Association. All rights reserved.

Copyright © 2015 American Medical Association. All rights reserved.

Figure 1. Schedule of the study

Insulin Delivery Systems Atlanta Diabetes Associates

From: Pharmacologic Therapy for Type 2 Diabetes Mellitus

Copyright © 2008 American Medical Association. All rights reserved.

Copyright © 2007 American Medical Association. All rights reserved.

From: United Kingdom Prospective Diabetes Study 17: A 9-Year Update of a Randomized, Controlled Trial on the Effect of Improved Metabolic Control on Complications.

HbA1c as a Marker of Glycaemic Control in Diabetes Care

51st Annual Scientific Session for the LIFE Investigators

366 میلیون نفر در جهان مبتلا به دیابت هستند.

The following slides highlight an educational report based on a Satellite Symposium presentation at the 2008 Canadian Cardiovascular Congress in Toronto.

Need to Know! Screening and Diagnosis of Kidney Disease in Diabetes

Short-Term Prognosis of Myocardial Injury, Type 1, and Type 2 Myocardial Infarction in the Emergency Unit Alain Putot, MD, MSc, Sophie Buet Derrida,

Schematic of traditional and non-traditional risk factors that account for the greatly increased risk of macrovascular disease in people with DKD. CRP,

Growing Diabetes Pandemic Worldwide

Summary of DURATION development program select efficacy results: absolute difference in change in A1C, body weight, systolic blood pressure, and LDL cholesterol.

What does STOP-2 tell us about management of hypertension?

Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.

Influence of possible intermediary variables on PR interval mean difference (95% CI) between HIV-infected (ART-naïve or ART-exposed) children and healthy.

Off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial Umberto Benedetto, MD, PhD, Douglas G. Altman,

A schematic representation of the effects of early intensive glycemic control in preventing initial microvascular complications and then macrovascular.

Cumulative incidences of events, according to glucose-control strategy

Connie W. Tsao et al. JCHF 2016;4:

Skin perfusion pressure in the prediction of healing in diabetic patients with ulcers or gangrene of the foot I. Faris, M.D., F.R.A.C.S., H. Duncan,

William T. Abraham et al. JCHF 2015;3:

Prevalence of microvascular and macrovascular complications compared between cohort 1 and cohort 2 for subjects with type 2 (A, upper panel) and type 1.

Baseline Characteristics of the Subjects*

(A) Rate of achieving targets for glycated hemoglobin (HbA1c), blood pressure (BP), and lipids in all subjects and (B) prevalence of nephropathy, retinopathy,

Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.

Chronic Disease Under Control: Managed Care Plan Distribution, 2006

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Change in (A) systolic blood pressure and (B) diastolic blood pressure over 5 years in response to 12-week intensive lifestyle intervention in a real-world.

Influence of possible intermediary variables on QTc interval mean difference (95% CI) between HIV-infected (ART-naïve or ART-exposed) children and healthy.

Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension Julian Segura, Carlos Campo, Luis M. Ruilope Kidney.

Schematic overview of diabetes-associated microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular (cerebrovascular, coronary artery,

Can you name this American symbol?

Associations between type of MI and incident HF

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Prevalence of clinically significant microvascular (green) and clinically significant macrovascular (yellow) disease alone and combined microvascular and.

Associations of body mass index (BMI) levels with achieving targets for glycated hemoglobin (HbA1c), blood pressure (BP), and lipids in the upper panels.

Atrasentan reduces albuminuria in diabetic apoE KO mice.

Odds ratios for development of type 2 diabetes in 8,633 healthy men, adjusted for age, examination year, BMI, smoking habit, alcohol intake, parental history.

Hazard ratios, with 95% confidence intervals as floating absolute risks, as estimate of association between category of updated mean haemoglobin A1c concentration.

Effects of placebo or carvedilol CR on 24-hour mean systolic blood pressure and diastolic blood pressure obtained by ambulatory monitoring in hypertensive.

Pathway to initial antihypertensive therapy in patients with diabetes

HR for mortality in ischemic heart disease.

HR for myocardial infarction.

Adjusted HRs for death from any cause and death from specific causes among patients with type 1 diabetes. Adjusted HRs for death from any cause and death.

Schematic diagram of the concept of hypoglycemia-associated autonomic failure and the pathogenesis of the syndromes of defective glucose counterregulation.

Presentation transcript:

Relationship between updated systolic blood pressure (SBP), right, and updated HbA1c, left, and the incidence of microvascular complications (closed symbols) and macrovascular, specifically myocardial infarction, complications (open symbols) of T2DM in the United Kingdom Prospective Diabetes Study.6. Relationship between updated systolic blood pressure (SBP), right, and updated HbA1c, left, and the incidence of microvascular complications (closed symbols) and macrovascular, specifically myocardial infarction, complications (open symbols) of T2DM in the United Kingdom Prospective Diabetes Study.6 Philip E. Cryer, and Belinda P. Childs Diabetes Spectr 2002;15:20-27 ©2002 by American Diabetes Association